US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nextcure Inc.

12.87

-0.0900-0.69%

Volume:25.04K

Turnover:329.15K

Market Cap:45.12M

PE:-0.54

High:13.80

Open:13.24

Low:12.52

Close:12.96

52wk High:15.74

52wk Low:2.69

Shares:3.51M

Float Shares:2.53M

Volume Ratio:1.21

T/O Rate:0.99%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-23.8671

EPS(LYR):-23.8819

ROE:-116.91%

ROA:-58.01%

PB:1.91

PE(LYR):-0.54

Loading ...

Overview Company News Filings

NextCure files to sell 2.52M shares of common stock for holders

BRIEF-NextCure Files For Offering Of Up To 2.52 Million Shares Of Common Stock By Selling Stockholders - SEC Filing

NextCure announces closing of $21.5M PIPE financing

NextCure Raises $21.5 Million in PIPE Financing

Press Release: NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts

NextCure Raises $21.5 Million in Private Placement of Common Stock

NextCure Inc - Proceeds to Extend Cash Runway Into First Half of 2027

THOMSON REUTERS

Press Release: NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules

NextCure Raised to Buy From Neutral by Ladenburg Thalmann

Biopharmaceutical firm NextCure Q3 net loss narrows

NextCure Inc. Highlights Progress in Targeted Cancer Therapies and ADC Trials in New Presentation

NextCure Inc expected to post a loss of $3.98 a share - Earnings Preview

NextCure Inc. Releases Corporate Presentation Highlighting Progress of Targeted Cancer Therapies and Ongoing Clinical Trials

BRIEF-NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The US

NextCure and Simcere Zaiming Expand Phase 1 Trial of SIM0505 (CDH6 ADC) into U.S.; First American Patient Dosed

NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of Sim0505 (Cdh6 ADC) Into the United States

THOMSON REUTERS

NextCure Inc - Trial to Accelerate Proof-of-Concept Data in 1H 2026

THOMSON REUTERS

NextCure Inc. Unveils Latest Developments in Cancer Therapy Targeting and Clinical Trials Progress

NextCure Inc. Announces Resignation of Chief Scientific Officer Solomon Langermann, Effective September 1, 2025

NextCure Inc. Files Initial Statement of Beneficial Ownership for Simcere Zaiming, Inc

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NXTC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NXTC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXTC\",,,,,undefined,":{"symbol":"NXTC","market":"US","secType":"STK","nameCN":"Nextcure Inc.","latestPrice":12.87,"timestamp":1768510800000,"preClose":12.96,"halted":0,"volume":25037,"delay":0,"floatShares":2534500,"shares":3505600,"eps":-23.867064,"marketStatus":"Pre-Mkt","change":-0.09,"latestTime":"01-16 06:38:08 EST","open":13.2415,"high":13.8045,"low":12.5183,"amount":329154.5232,"amplitude":0.099244,"askPrice":13.88,"askSize":100,"bidPrice":10.25,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-23.867064,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1768573800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":12.87,"postHourTrading":{"tag":"盘后","latestPrice":12.87,"preClose":12.87,"latestTime":"16:10 EST","volume":8,"amount":102.96,"timestamp":1768511404341},"volumeRatio":1.2096922206661689,"impliedVol":0.7756,"impliedVolPercentile":0.525},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXTC\",,,,,undefined,":{"symbol":"NXTC","floatShares":2534500,"roa":"-58.01%","roe":"-116.91%","lyrEps":-23.88188,"volumeRatio":1.2096922206661689,"shares":3505600,"dividePrice":0,"high":13.8045,"amplitude":0.099244,"preClose":12.96,"low":12.5183,"week52Low":2.688,"pbRate":"1.91","week52High":15.7399,"institutionHeld":0,"latestPrice":12.87,"eps":-23.867064,"divideRate":0,"volume":25037,"delay":0,"ttmEps":-23.867064,"open":13.2415,"prevYearClose":14.19,"prevWeekClose":13.37,"prevMonthClose":14.19,"prevQuarterClose":14.19,"fiveDayClose":13.59,"twentyDayClose":11.12,"sixtyDayClose":10.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NXTC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-05","symbol":"NXTC","fiscalQuarterEnding":"2025/09","expectedEps":-4.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":-3.22},{"market":"US","date":"2025-08-07","symbol":"NXTC","fiscalQuarterEnding":"2025/06","expectedEps":-4.62,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-11.29},{"market":"US","date":"2025-07-14","symbol":"NXTC","defaultRemindTime":1752499800000,"type":"split","dateTimestamp":1752465600000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2025-05-01","symbol":"NXTC","fiscalQuarterEnding":"2025/03","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2025-03-06","symbol":"NXTC","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.41}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NXTC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NXTC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1762578000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NXTC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NXTC","date":"2026-01-14","current":-0.539237,"percent":0.402998,"low":-11.925438,"twenty":-2.369206,"median":-0.672773,"eighty":-0.474718,"high":-0.135872,"avg":-1.638315,"sd":2.206438,"marketCap":46835096},"quantilePoints":[{"date":"2021-01-22","current":-11.684867,"twenty":-40.000609,"median":-22.606872,"eighty":-10.913337,"marketCap":374722010},{"date":"2021-01-29","current":-9.957913,"twenty":-39.883152,"median":-22.509937,"eighty":-10.825686,"marketCap":319340301},{"date":"2021-02-05","current":-10.838574,"twenty":-39.63991,"median":-22.278137,"eighty":-10.79991,"marketCap":347582217},{"date":"2021-02-12","current":-11.495847,"twenty":-39.538174,"median":-21.964329,"eighty":-10.816304,"marketCap":368660330},{"date":"2021-02-19","current":-11.46148,"twenty":-39.345801,"median":-21.898827,"eighty":-10.82087,"marketCap":367558207},{"date":"2021-02-26","current":-9.760301,"twenty":-39.260394,"median":-21.806107,"eighty":-10.758085,"marketCap":313003091},{"date":"2021-03-05","current":-8.528138,"twenty":-39.170898,"median":-21.646686,"eighty":-10.645232,"marketCap":312155423},{"date":"2021-03-12","current":-9.553625,"twenty":-38.728214,"median":-21.095397,"eighty":-10.591416,"marketCap":349691353},{"date":"2021-03-19","current":-8.995639,"twenty":-38.607359,"median":-20.947129,"eighty":-10.574805,"marketCap":329267391},{"date":"2021-03-26","current":-7.887208,"twenty":-38.189615,"median":-20.53714,"eighty":-10.497479,"marketCap":288695466},{"date":"2021-04-01","current":-7.600674,"twenty":-38.036186,"median":-20.431722,"eighty":-10.476459,"marketCap":278207485},{"date":"2021-04-09","current":-7.253818,"twenty":-37.964046,"median":-19.91028,"eighty":-10.436985,"marketCap":265511509},{"date":"2021-04-16","current":-7.103011,"twenty":-37.911895,"median":-19.800828,"eighty":-10.344839,"marketCap":259991519},{"date":"2021-04-23","current":-7.163334,"twenty":-37.74639,"median":-19.661526,"eighty":-10.243879,"marketCap":262199515},{"date":"2021-04-30","current":-6.615264,"twenty":-37.564472,"median":-19.472473,"eighty":-10.134144,"marketCap":242138498},{"date":"2021-05-07","current":-3.491362,"twenty":-37.360971,"median":-19.224757,"eighty":-10.031235,"marketCap":219498410},{"date":"2021-05-14","current":-3.574803,"twenty":-37.262304,"median":-18.761346,"eighty":-9.925264,"marketCap":224744284},{"date":"2021-05-21","current":-3.636286,"twenty":-37.225304,"median":-18.626168,"eighty":-9.822053,"marketCap":228609665},{"date":"2021-05-28","current":-3.447445,"twenty":-37.182137,"median":-18.248602,"eighty":-9.736327,"marketCap":216737424},{"date":"2021-06-04","current":-3.337654,"twenty":-37.110015,"median":-18.099377,"eighty":-9.595782,"marketCap":209834958},{"date":"2021-06-11","current":-3.530886,"twenty":-36.851954,"median":-17.442639,"eighty":-9.50942,"marketCap":221983298},{"date":"2021-06-18","current":-3.447445,"twenty":-36.561471,"median":-16.639291,"eighty":-9.440553,"marketCap":216737424},{"date":"2021-06-25","current":-3.724119,"twenty":-36.369847,"median":-16.350032,"eighty":-9.382261,"marketCap":234131638},{"date":"2021-07-02","current":-3.508928,"twenty":-36.147059,"median":-16.127312,"eighty":-9.350036,"marketCap":220602805},{"date":"2021-07-09","current":-3.456228,"twenty":-36.097991,"median":-16.01354,"eighty":-9.322118,"marketCap":217289621},{"date":"2021-07-16","current":-3.175163,"twenty":-35.890223,"median":-15.776513,"eighty":-9.179494,"marketCap":199619309},{"date":"2021-07-23","current":-3.100505,"twenty":-35.291831,"median":-15.643778,"eighty":-9.071426,"marketCap":194925632},{"date":"2021-07-30","current":-3.043413,"twenty":-34.894035,"median":-15.108422,"eighty":-8.999074,"marketCap":191336350},{"date":"2021-08-06","current":-3.171159,"twenty":-34.11786,"median":-14.908005,"eighty":-8.92174,"marketCap":210400049},{"date":"2021-08-13","current":-3.000532,"twenty":-33.677665,"median":-14.743075,"eighty":-8.837891,"marketCap":199079311},{"date":"2021-08-20","current":-2.9173,"twenty":-33.374217,"median":-14.648264,"eighty":-8.700071,"marketCap":193557000},{"date":"2021-08-27","current":-3.087926,"twenty":-33.313366,"median":-14.54037,"eighty":-8.596004,"marketCap":204877738},{"date":"2021-09-03","current":-3.221098,"twenty":-33.275794,"median":-14.353002,"eighty":-8.480121,"marketCap":213713435},{"date":"2021-09-10","current":-3.008855,"twenty":-33.23598,"median":-14.322168,"eighty":-8.271766,"marketCap":199631542},{"date":"2021-09-17","current":-2.913138,"twenty":-33.053529,"median":-14.252792,"eighty":-7.645917,"marketCap":193280885},{"date":"2021-09-24","current":-2.933946,"twenty":-33.005428,"median":-14.202654,"eighty":-7.51019,"marketCap":194661462},{"date":"2021-10-01","current":-3.146189,"twenty":-32.890386,"median":-14.0755,"eighty":-7.344302,"marketCap":208743355},{"date":"2021-10-08","current":-3.171159,"twenty":-32.869789,"median":-13.861335,"eighty":-7.118092,"marketCap":210400049},{"date":"2021-10-15","current":-3.633099,"twenty":-32.860746,"median":-13.744915,"eighty":-6.974825,"marketCap":241048875},{"date":"2021-10-22","current":-3.441665,"twenty":-32.779509,"median":-13.705498,"eighty":-6.816478,"marketCap":228347559},{"date":"2021-10-29","current":-3.420856,"twenty":-32.730233,"median":-13.510535,"eighty":-6.034448,"marketCap":226966982},{"date":"2021-11-05","current":-3.502552,"twenty":-32.66811,"median":-13.207877,"eighty":-3.671419,"marketCap":237861814},{"date":"2021-11-12","current":-2.615727,"twenty":-32.637276,"median":-13.133676,"eighty":-3.636286,"marketCap":177636639},{"date":"2021-11-19","current":-2.359443,"twenty":-32.603797,"median":-13.002396,"eighty":-3.614328,"marketCap":160232116},{"date":"2021-11-26","current":-2.448939,"twenty":-32.599568,"median":-12.990981,"eighty":-3.604396,"marketCap":166309886},{"date":"2021-12-03","current":-2.326899,"twenty":-32.562341,"median":-12.814039,"eighty":-3.59237,"marketCap":158022018},{"date":"2021-12-10","current":-2.489619,"twenty":-32.440719,"median":-12.477277,"eighty":-3.574803,"marketCap":169072509},{"date":"2021-12-17","current":-2.379783,"twenty":-32.255361,"median":-11.921142,"eighty":-3.545774,"marketCap":161613427},{"date":"2021-12-23","current":-2.514027,"twenty":-32.089537,"median":-11.883665,"eighty":-3.530886,"marketCap":170730082},{"date":"2021-12-31","current":-2.440803,"twenty":-31.909182,"median":-11.769509,"eighty":-3.517711,"marketCap":165757362},{"date":"2022-01-07","current":-2.294355,"twenty":-31.794602,"median":-11.710643,"eighty":-3.506378,"marketCap":155811920},{"date":"2022-01-14","current":-2.310627,"twenty":-31.648466,"median":-11.598274,"eighty":-3.489605,"marketCap":156916969},{"date":"2022-01-21","current":-2.180451,"twenty":-31.463026,"median":-11.504439,"eighty":-3.473795,"marketCap":148076576},{"date":"2022-01-28","current":-2.184519,"twenty":-31.270312,"median":-11.461384,"eighty":-3.453593,"marketCap":148352838},{"date":"2022-02-04","current":-2.172315,"twenty":-31.190863,"median":-11.27246,"eighty":-3.443977,"marketCap":147524052},{"date":"2022-02-11","current":-2.086886,"twenty":-31.093821,"median":-11.17795,"eighty":-3.412312,"marketCap":141722544},{"date":"2022-02-18","current":-2.09909,"twenty":-31.029239,"median":-10.947584,"eighty":-3.353464,"marketCap":142551331},{"date":"2022-02-25","current":-2.034002,"twenty":-31.012381,"median":-10.919045,"eighty":-3.299185,"marketCap":138131135},{"date":"2022-03-04","current":-1.901853,"twenty":-30.903906,"median":-10.889639,"eighty":-3.262715,"marketCap":131967682},{"date":"2022-03-11","current":-1.961785,"twenty":-30.564854,"median":-10.825686,"eighty":-3.217769,"marketCap":136126327},{"date":"2022-03-18","current":-2.045691,"twenty":-30.468636,"median":-10.808107,"eighty":-3.180314,"marketCap":141948431},{"date":"2022-03-25","current":-2.017722,"twenty":-30.27946,"median":-10.764934,"eighty":-3.171159,"marketCap":140007730},{"date":"2022-04-01","current":-1.981763,"twenty":-30.206073,"median":-10.690732,"eighty":-3.162158,"marketCap":137512542},{"date":"2022-04-08","current":-2.105623,"twenty":-30.113715,"median":-10.627946,"eighty":-3.149121,"marketCap":146107076},{"date":"2022-04-14","current":-2.00174,"twenty":-30.083493,"median":-10.593707,"eighty":-3.137866,"marketCap":138898758},{"date":"2022-04-22","current":-1.869889,"twenty":-30.015267,"median":-10.582284,"eighty":-3.117058,"marketCap":129749738},{"date":"2022-04-29","current":-1.663262,"twenty":-29.933561,"median":-10.576523,"eighty":-3.087926,"marketCap":115412119},{"date":"2022-05-06","current":-1.435368,"twenty":-29.852185,"median":-10.553745,"eighty":-3.075441,"marketCap":105439227},{"date":"2022-05-13","current":-1.337158,"twenty":-29.771616,"median":-10.490605,"eighty":-3.062957,"marketCap":98224964},{"date":"2022-05-20","current":-1.43159,"twenty":-29.770644,"median":-10.475071,"eighty":-3.029664,"marketCap":105161755},{"date":"2022-05-27","current":-1.507136,"twenty":-29.640178,"median":-10.456712,"eighty":-3.000532,"marketCap":110711188},{"date":"2022-06-03","current":-1.575127,"twenty":-29.577676,"median":-10.433881,"eighty":-2.930617,"marketCap":115705678},{"date":"2022-06-10","current":-1.790432,"twenty":-29.513656,"median":-10.370737,"eighty":-2.89233,"marketCap":131521562},{"date":"2022-06-17","current":-1.620454,"twenty":-29.488512,"median":-10.301585,"eighty":-2.863198,"marketCap":119035337},{"date":"2022-06-24","current":-1.756437,"twenty":-29.455895,"median":-10.251231,"eighty":-2.824912,"marketCap":129024317},{"date":"2022-07-01","current":-1.699777,"twenty":-29.392293,"median":-10.19986,"eighty":-2.630372,"marketCap":124862242},{"date":"2022-07-08","current":-1.816873,"twenty":-29.327482,"median":-10.133412,"eighty":-2.540062,"marketCap":133463863},{"date":"2022-07-15","current":-1.726218,"twenty":-29.267353,"median":-10.068581,"eighty":-2.52379,"marketCap":126804544},{"date":"2022-07-22","current":-1.703555,"twenty":-29.221057,"median":-9.983688,"eighty":-2.496128,"marketCap":125139714},{"date":"2022-07-29","current":-1.624232,"twenty":-29.079772,"median":-9.932137,"eighty":-2.464397,"marketCap":119312809},{"date":"2022-08-05","current":-1.780832,"twenty":-28.947368,"median":-9.846219,"eighty":-2.440803,"marketCap":130697055},{"date":"2022-08-12","current":-1.924509,"twenty":-28.936385,"median":-9.811852,"eighty":-2.418022,"marketCap":141241615},{"date":"2022-08-19","current":-1.803518,"twenty":-28.883293,"median":-9.748914,"eighty":-2.374901,"marketCap":132361985},{"date":"2022-08-26","current":-1.663622,"twenty":-28.776985,"median":-9.725934,"eighty":-2.364325,"marketCap":122094913},{"date":"2022-09-02","current":-1.538851,"twenty":-28.698739,"median":-9.559959,"eighty":-2.328526,"marketCap":112937795},{"date":"2022-09-09","current":-1.440546,"twenty":-28.685307,"median":-9.528322,"eighty":-2.312254,"marketCap":105723095},{"date":"2022-09-16","current":-1.463232,"twenty":-28.673616,"median":-9.497799,"eighty":-2.295169,"marketCap":107388026},{"date":"2022-09-23","current":-1.122945,"twenty":-28.646583,"median":-9.444387,"eighty":-2.230894,"marketCap":82414066},{"date":"2022-09-30","current":-1.039764,"twenty":-28.558519,"median":-9.383643,"eighty":-2.193469,"marketCap":76309321},{"date":"2022-10-07","current":-1.145631,"twenty":-28.537743,"median":-9.377244,"eighty":-2.176383,"marketCap":84078997},{"date":"2022-10-14","current":-1.020859,"twenty":-28.513281,"median":-9.350036,"eighty":-2.135702,"marketCap":74921878},{"date":"2022-10-21","current":-0.903649,"twenty":-28.42673,"median":-9.335006,"eighty":-2.100397,"marketCap":66319737},{"date":"2022-10-28","current":-0.949021,"twenty":-28.352993,"median":-9.304935,"eighty":-2.086886,"marketCap":69649598},{"date":"2022-11-04","current":-0.739439,"twenty":-28.262004,"median":-9.197537,"eighty":-2.063915,"marketCap":54993581},{"date":"2022-11-11","current":-0.661014,"twenty":-28.116474,"median":-9.086124,"eighty":-2.04649,"marketCap":49160928},{"date":"2022-11-18","current":-0.556447,"twenty":-28.052158,"median":-9.067704,"eighty":-2.034742,"marketCap":41384058},{"date":"2022-11-25","current":-0.541509,"twenty":-28.027666,"median":-9.029996,"eighty":-2.025866,"marketCap":40273077},{"date":"2022-12-02","current":-0.52657,"twenty":-27.675038,"median":-8.973018,"eighty":-2.009731,"marketCap":39162095},{"date":"2022-12-09","current":-0.504163,"twenty":-27.605334,"median":-8.926895,"eighty":-1.993322,"marketCap":37495623},{"date":"2022-12-16","current":-0.474287,"twenty":-27.600864,"median":-8.882534,"eighty":-1.977767,"marketCap":35273660},{"date":"2022-12-23","current":-0.459349,"twenty":-27.565163,"median":-8.802314,"eighty":-1.962318,"marketCap":34162679},{"date":"2022-12-30","current":-0.52657,"twenty":-27.529121,"median":-8.737875,"eighty":-1.958582,"marketCap":39162095},{"date":"2023-01-06","current":-0.604996,"twenty":-27.456005,"median":-8.69062,"eighty":-1.937028,"marketCap":44994748},{"date":"2023-01-13","current":-0.601261,"twenty":-27.359955,"median":-8.626181,"eighty":-1.90966,"marketCap":44717002},{"date":"2023-01-20","current":-0.646076,"twenty":-27.246132,"median":-8.574631,"eighty":-1.905849,"marketCap":48049947},{"date":"2023-01-27","current":-0.623669,"twenty":-26.955846,"median":-8.480121,"eighty":-1.890112,"marketCap":46383475},{"date":"2023-02-03","current":-0.619934,"twenty":-26.621528,"median":-8.294387,"eighty":-1.855725,"marketCap":46105729},{"date":"2023-02-10","current":-0.634872,"twenty":-26.482469,"median":-7.977692,"eighty":-1.830429,"marketCap":47216711},{"date":"2023-02-17","current":-0.590058,"twenty":-26.415476,"median":-7.645917,"eighty":-1.805709,"marketCap":43883766},{"date":"2023-02-24","current":-0.593792,"twenty":-26.370562,"median":-7.547892,"eighty":-1.802115,"marketCap":44161512},{"date":"2023-03-03","current":-0.557475,"twenty":-26.343023,"median":-7.461178,"eighty":-1.784389,"marketCap":41661804},{"date":"2023-03-10","current":-0.553759,"twenty":-26.293765,"median":-7.344302,"eighty":-1.767869,"marketCap":41384058},{"date":"2023-03-17","current":-0.59464,"twenty":-26.246562,"median":-7.208576,"eighty":-1.729995,"marketCap":44439257},{"date":"2023-03-24","current":-0.579774,"twenty":-26.136983,"median":-7.118092,"eighty":-1.711864,"marketCap":43328276},{"date":"2023-03-31","current":-0.550042,"twenty":-26.104953,"median":-7.050229,"eighty":-1.703887,"marketCap":41106313},{"date":"2023-04-06","current":-0.546326,"twenty":-26.003804,"median":-6.933353,"eighty":-1.701432,"marketCap":40828567},{"date":"2023-04-14","current":-0.5742,"twenty":-25.708785,"median":-6.831559,"eighty":-1.688445,"marketCap":42911658},{"date":"2023-04-21","current":-0.576058,"twenty":-25.430624,"median":-6.685709,"eighty":-1.663262,"marketCap":43050530},{"date":"2023-04-28","current":-0.561192,"twenty":-25.396908,"median":-6.034448,"eighty":-1.639341,"marketCap":41939549},{"date":"2023-05-05","current":-0.591934,"twenty":-25.144034,"median":-3.755599,"eighty":-1.624232,"marketCap":44237008},{"date":"2023-05-12","current":-0.705187,"twenty":-25.135605,"median":-3.667028,"eighty":-1.620454,"marketCap":49523192},{"date":"2023-05-19","current":-0.704642,"twenty":-25.08503,"median":-3.66044,"eighty":-1.620454,"marketCap":49484904},{"date":"2023-05-22","current":-0.713441,"twenty":-25.034456,"median":-3.653853,"eighty":-1.616864,"marketCap":50102839},{"date":"2023-06-09","current":-0.701551,"twenty":-24.933307,"median":-3.649461,"eighty":-1.591082,"marketCap":49267792},{"date":"2023-06-15","current":-0.642097,"twenty":-24.710778,"median":-3.636286,"eighty":-1.5824,"marketCap":45092555},{"date":"2023-06-30","current":-0.713441,"twenty":-24.538824,"median":-3.634692,"eighty":-1.577253,"marketCap":50102839},{"date":"2023-07-07","current":-0.709478,"twenty":-23.845136,"median":-3.624776,"eighty":-1.54112,"marketCap":49824490},{"date":"2023-07-21","current":-0.709478,"twenty":-23.117786,"median":-3.614328,"eighty":-1.50226,"marketCap":49824490},{"date":"2023-07-28","current":-0.681733,"twenty":-23.046872,"median":-3.602675,"eighty":-1.463703,"marketCap":47876046},{"date":"2023-08-04","current":-0.681733,"twenty":-23.006412,"median":-3.59237,"eighty":-1.440546,"marketCap":47876046},{"date":"2023-08-11","current":-0.686417,"twenty":-22.947409,"median":-3.589846,"eighty":-1.432346,"marketCap":48163144},{"date":"2023-08-18","current":-0.642772,"twenty":-22.917064,"median":-3.574803,"eighty":-1.372977,"marketCap":45100748},{"date":"2023-08-25","current":-0.61103,"twenty":-22.873232,"median":-3.566382,"eighty":-1.367642,"marketCap":42873550},{"date":"2023-09-01","current":-0.579288,"twenty":-22.836144,"median":-3.53967,"eighty":-1.334136,"marketCap":40646353},{"date":"2023-09-08","current":-0.575321,"twenty":-22.741738,"median":-3.530886,"eighty":-1.280499,"marketCap":40367953},{"date":"2023-09-15","current":-0.547547,"twenty":-22.669256,"median":-3.524299,"eighty":-1.145631,"marketCap":38419155},{"date":"2023-09-22","current":-0.531676,"twenty":-22.63216,"median":-3.517711,"eighty":-1.111602,"marketCap":37305557},{"date":"2023-09-29","current":-0.511837,"twenty":-22.606872,"median":-3.511124,"eighty":-1.06245,"marketCap":35913558},{"date":"2023-10-06","current":-0.499934,"twenty":-22.573156,"median":-3.495753,"eighty":-1.039764,"marketCap":35078359},{"date":"2023-10-13","current":-0.491998,"twenty":-22.514152,"median":-3.489166,"eighty":-1.017078,"marketCap":34521560},{"date":"2023-10-20","current":-0.519773,"twenty":-22.505723,"median":-3.473795,"eighty":-0.956583,"marketCap":36470358},{"date":"2023-10-27","current":-0.412644,"twenty":-22.45852,"median":-3.473795,"eighty":-0.946752,"marketCap":28953566},{"date":"2023-11-03","current":-0.464224,"twenty":-22.343884,"median":-3.458424,"eighty":-0.937493,"marketCap":32572762},{"date":"2023-11-10","current":-0.455431,"twenty":-22.193846,"median":-3.449988,"eighty":-0.733353,"marketCap":29856238},{"date":"2023-11-17","current":-0.497995,"twenty":-22.043808,"median":-3.444555,"eighty":-0.713441,"marketCap":32646541},{"date":"2023-11-24","current":-0.536302,"twenty":-21.990775,"median":-3.420975,"eighty":-0.709478,"marketCap":35157814},{"date":"2023-12-01","current":-0.502251,"twenty":-21.915966,"median":-3.412312,"eighty":-0.704751,"marketCap":32925571},{"date":"2023-12-08","current":-0.532046,"twenty":-21.898827,"median":-3.379374,"eighty":-0.697587,"marketCap":34878783},{"date":"2023-12-15","current":-0.497995,"twenty":-21.888712,"median":-3.327628,"eighty":-0.693366,"marketCap":32646541},{"date":"2023-12-22","current":-0.476713,"twenty":-21.839823,"median":-3.284954,"eighty":-0.68402,"marketCap":31251390},{"date":"2023-12-29","current":-0.489482,"twenty":-21.814536,"median":-3.2752,"eighty":-0.681733,"marketCap":32088481},{"date":"2024-01-05","current":-0.510764,"twenty":-21.779134,"median":-3.262715,"eighty":-0.679782,"marketCap":33483632},{"date":"2024-01-12","current":-0.497995,"twenty":-21.725188,"median":-3.241038,"eighty":-0.674514,"marketCap":32646541},{"date":"2024-01-19","current":-0.489482,"twenty":-21.681649,"median":-3.216937,"eighty":-0.673806,"marketCap":32088481},{"date":"2024-01-26","current":-0.506507,"twenty":-21.57632,"median":-3.183644,"eighty":-0.658026,"marketCap":33204602},{"date":"2024-02-02","current":-0.553327,"twenty":-21.441436,"median":-3.179482,"eighty":-0.643433,"marketCap":36273935},{"date":"2024-02-09","current":-0.553327,"twenty":-21.090872,"median":-3.171159,"eighty":-0.639246,"marketCap":36273935},{"date":"2024-02-16","current":-0.600147,"twenty":-21.055916,"median":-3.170771,"eighty":-0.634872,"marketCap":39343268},{"date":"2024-02-23","current":-0.646967,"twenty":-20.988483,"median":-3.161988,"eighty":-0.634872,"marketCap":42412601},{"date":"2024-03-01","current":-0.736351,"twenty":-20.905775,"median":-3.156169,"eighty":-0.634872,"marketCap":48272236},{"date":"2024-03-08","current":-0.7023,"twenty":-20.829927,"median":-3.146189,"eighty":-0.634872,"marketCap":46039994},{"date":"2024-03-15","current":-0.625686,"twenty":-20.53714,"median":-3.136752,"eighty":-0.634872,"marketCap":41017449},{"date":"2024-03-22","current":-0.747367,"twenty":-20.432162,"median":-3.118071,"eighty":-0.631138,"marketCap":46877085},{"date":"2024-03-28","current":-0.860806,"twenty":-20.43181,"median":-3.100505,"eighty":-0.631672,"marketCap":53992357},{"date":"2024-04-05","current":-0.9609,"twenty":-20.149891,"median":-3.087926,"eighty":-0.634259,"marketCap":60270538},{"date":"2024-04-12","current":-0.836339,"twenty":-19.944111,"median":-3.078546,"eighty":-0.634872,"marketCap":52457690},{"date":"2024-04-19","current":-0.700191,"twenty":-19.91028,"median":-3.074798,"eighty":-0.634872,"marketCap":43918063},{"date":"2024-04-26","current":-0.575316,"twenty":-19.842002,"median":-3.07128,"eighty":-0.634872,"marketCap":36085542},{"date":"2024-05-03","current":-0.664512,"twenty":-19.805649,"median":-3.045609,"eighty":-0.631672,"marketCap":41680200},{"date":"2024-05-10","current":-0.75492,"twenty":-19.788888,"median":-3.029664,"eighty":-0.633645,"marketCap":48114057},{"date":"2024-05-17","current":-0.724196,"twenty":-19.653566,"median":-2.983885,"eighty":-0.633645,"marketCap":46155926},{"date":"2024-05-24","current":-0.70664,"twenty":-18.732713,"median":-2.902734,"eighty":-0.633645,"marketCap":45036995},{"date":"2024-05-31","current":-0.693473,"twenty":-18.26814,"median":-2.86736,"eighty":-0.633645,"marketCap":44197796},{"date":"2024-06-07","current":-0.539855,"twenty":-18.148679,"median":-2.761182,"eighty":-0.627403,"marketCap":34407145},{"date":"2024-06-14","current":-0.702251,"twenty":-18.173329,"median":-2.562843,"eighty":-0.627403,"marketCap":44757262},{"date":"2024-06-21","current":-0.65836,"twenty":-18.19798,"median":-2.526231,"eighty":-0.627403,"marketCap":41959933},{"date":"2024-06-28","current":-0.719807,"twenty":-18.26814,"median":-2.514027,"eighty":-0.627343,"marketCap":45876193},{"date":"2024-07-05","current":-0.689084,"twenty":-18.26814,"median":-2.489619,"eighty":-0.627343,"marketCap":43918063},{"date":"2024-07-12","current":-0.700056,"twenty":-18.26814,"median":-2.440803,"eighty":-0.627343,"marketCap":44617395},{"date":"2024-07-15","current":-0.724196,"twenty":-18.26814,"median":-2.440803,"eighty":-0.627343,"marketCap":46155926},{"date":"2024-08-02","current":-0.70664,"twenty":-14.460919,"median":-2.375715,"eighty":-0.625686,"marketCap":45036995},{"date":"2024-08-09","current":-0.71219,"twenty":-14.245084,"median":-2.353341,"eighty":-0.625686,"marketCap":43642310},{"date":"2024-08-16","current":-0.71219,"twenty":-13.890499,"median":-2.320797,"eighty":-0.625686,"marketCap":43642310},{"date":"2024-08-23","current":-0.721321,"twenty":-13.207877,"median":-2.296389,"eighty":-0.625686,"marketCap":44201827},{"date":"2024-08-30","current":-0.716756,"twenty":-13.002396,"median":-2.223165,"eighty":-0.625686,"marketCap":43922068},{"date":"2024-09-06","current":-0.657406,"twenty":-12.819746,"median":-2.186553,"eighty":-0.625686,"marketCap":40285209},{"date":"2024-09-13","current":-0.630015,"twenty":-11.925438,"median":-2.170281,"eighty":-0.623669,"marketCap":38606659},{"date":"2024-09-20","current":-0.652841,"twenty":-11.769509,"median":-2.105623,"eighty":-0.623669,"marketCap":40005451},{"date":"2024-09-27","current":-0.64371,"twenty":-11.598274,"median":-2.086886,"eighty":-0.623669,"marketCap":39445934},{"date":"2024-10-04","current":-0.598057,"twenty":-11.461287,"median":-2.062478,"eighty":-0.621429,"marketCap":36648350},{"date":"2024-10-11","current":-0.630015,"twenty":-11.143583,"median":-2.043693,"eighty":-0.618966,"marketCap":38606659},{"date":"2024-10-18","current":-0.661972,"twenty":-10.913337,"median":-2.027788,"eighty":-0.618966,"marketCap":40564968},{"date":"2024-10-25","current":-0.616319,"twenty":-10.822012,"median":-2.005736,"eighty":-0.617173,"marketCap":37767384},{"date":"2024-10-31","current":-0.616319,"twenty":-10.764934,"median":-1.98954,"eighty":-0.617173,"marketCap":37767384},{"date":"2024-11-08","current":-0.602623,"twenty":-10.621175,"median":-1.977767,"eighty":-0.616319,"marketCap":36928108},{"date":"2024-11-15","current":-0.640617,"twenty":-10.582284,"median":-1.960778,"eighty":-0.616319,"marketCap":37487625},{"date":"2024-11-22","current":-0.617393,"twenty":-10.508965,"median":-1.933817,"eighty":-0.616319,"marketCap":36128622},{"date":"2024-11-29","current":-0.559961,"twenty":-10.470905,"median":-1.905849,"eighty":-0.612684,"marketCap":32767820},{"date":"2024-12-06","current":-0.521673,"twenty":-10.415615,"median":-1.89048,"eighty":-0.609811,"marketCap":30527285},{"date":"2024-12-13","current":-0.521673,"twenty":-10.270434,"median":-1.848889,"eighty":-0.607188,"marketCap":30527285},{"date":"2024-12-20","current":-0.454669,"twenty":-10.143923,"median":-1.824428,"eighty":-0.604996,"marketCap":26606349},{"date":"2024-12-27","current":-0.396185,"twenty":-10.050315,"median":-1.805541,"eighty":-0.602075,"marketCap":23183933},{"date":"2025-01-03","current":-0.393409,"twenty":-9.932137,"median":-1.794209,"eighty":-0.601294,"marketCap":23021494},{"date":"2025-01-10","current":-0.407288,"twenty":-9.818652,"median":-1.777211,"eighty":-0.600815,"marketCap":23833688},{"date":"2025-01-17","current":-0.366607,"twenty":-9.72937,"median":-1.735661,"eighty":-0.598057,"marketCap":21453119},{"date":"2025-01-24","current":-0.410638,"twenty":-9.543598,"median":-1.712997,"eighty":-0.59464,"marketCap":24029734},{"date":"2025-01-31","current":-0.382401,"twenty":-9.475453,"median":-1.703555,"eighty":-0.59153,"marketCap":22377340},{"date":"2025-02-07","current":-0.378094,"twenty":-9.382261,"median":-1.696,"eighty":-0.587316,"marketCap":22125280},{"date":"2025-02-14","current":-0.346793,"twenty":-9.348751,"median":-1.663442,"eighty":-0.58313,"marketCap":20293643},{"date":"2025-02-21","current":-0.359428,"twenty":-9.263694,"median":-1.646895,"eighty":-0.580377,"marketCap":21033019},{"date":"2025-02-28","current":-0.368043,"twenty":-9.078223,"median":-1.623756,"eighty":-0.579114,"marketCap":21537139},{"date":"2025-03-07","current":-0.341194,"twenty":-8.986591,"median":-1.61447,"eighty":-0.575321,"marketCap":19965965},{"date":"2025-03-14","current":-0.362325,"twenty":-8.893686,"median":-1.569098,"eighty":-0.574813,"marketCap":20164812},{"date":"2025-03-21","current":-0.309184,"twenty":-8.741312,"median":-1.507136,"eighty":-0.570766,"marketCap":17207306},{"date":"2025-03-28","current":-0.267063,"twenty":-8.611093,"median":-1.463232,"eighty":-0.568625,"marketCap":14863147},{"date":"2025-04-04","current":-0.199782,"twenty":-8.476684,"median":-1.440546,"eighty":-0.565874,"marketCap":11118653},{"date":"2025-04-11","current":-0.135872,"twenty":-7.959595,"median":-1.420259,"eighty":-0.561581,"marketCap":7561804},{"date":"2025-04-17","current":-0.168481,"twenty":-7.569005,"median":-1.371154,"eighty":-0.560181,"marketCap":9376637},{"date":"2025-04-25","current":-0.210853,"twenty":-7.344302,"median":-1.337158,"eighty":-0.559654,"marketCap":11734800},{"date":"2025-05-02","current":-0.24155,"twenty":-7.11206,"median":-1.276722,"eighty":-0.557475,"marketCap":13443208},{"date":"2025-05-09","current":-0.217729,"twenty":-6.877785,"median":-1.134288,"eighty":-0.555287,"marketCap":10782573},{"date":"2025-05-16","current":-0.23336,"twenty":-6.545868,"median":-1.070012,"eighty":-0.553759,"marketCap":11556678},{"date":"2025-05-23","current":-0.281561,"twenty":-3.703039,"median":-1.051107,"eighty":-0.550181,"marketCap":13943749},{"date":"2025-05-30","current":-0.281165,"twenty":-3.644191,"median":-1.027629,"eighty":-0.549404,"marketCap":13924114},{"date":"2025-06-06","current":-0.280655,"twenty":-3.614328,"median":-0.99204,"eighty":-0.545892,"marketCap":13898869},{"date":"2025-06-13","current":-0.368335,"twenty":-3.59237,"median":-0.956583,"eighty":-0.542337,"marketCap":18241039},{"date":"2025-06-20","current":-0.256356,"twenty":-3.57483,"median":-0.939569,"eighty":-0.54061,"marketCap":12695516},{"date":"2025-06-27","current":-0.260547,"twenty":-3.545774,"median":-0.894462,"eighty":-0.536302,"marketCap":12903087},{"date":"2025-07-03","current":-0.24684,"twenty":-3.530008,"median":-0.849684,"eighty":-0.53175,"marketCap":12224273},{"date":"2025-07-11","current":-0.265192,"twenty":-3.51332,"median":-0.810837,"eighty":-0.528292,"marketCap":13133099},{"date":"2025-07-18","current":-0.242139,"twenty":-3.491362,"median":-0.74804,"eighty":-0.526798,"marketCap":11991446},{"date":"2025-07-25","current":-0.248275,"twenty":-3.472038,"median":-0.736291,"eighty":-0.52374,"marketCap":12295323},{"date":"2025-08-01","current":-0.268031,"twenty":-3.449479,"median":-0.731713,"eighty":-0.523533,"marketCap":13273713},{"date":"2025-08-08","current":-0.275326,"twenty":-3.419147,"median":-0.729434,"eighty":-0.521673,"marketCap":13634994},{"date":"2025-08-15","current":-0.226104,"twenty":-3.369274,"median":-0.724196,"eighty":-0.519376,"marketCap":13775811},{"date":"2025-08-22","current":-0.224448,"twenty":-3.275977,"median":-0.720564,"eighty":-0.512543,"marketCap":13674922},{"date":"2025-08-29","current":-0.225326,"twenty":-3.23705,"median":-0.71609,"eighty":-0.510764,"marketCap":13728444},{"date":"2025-09-05","current":-0.216981,"twenty":-3.183644,"median":-0.713441,"eighty":-0.507869,"marketCap":13219983},{"date":"2025-09-12","current":-0.238942,"twenty":-3.171159,"median":-0.710254,"eighty":-0.502633,"marketCap":14558038},{"date":"2025-09-19","current":-0.248456,"twenty":-3.161988,"median":-0.708059,"eighty":-0.500566,"marketCap":15137683},{"date":"2025-09-26","current":-0.253876,"twenty":-3.144524,"median":-0.703851,"eighty":-0.497995,"marketCap":15467915},{"date":"2025-10-03","current":-0.252699,"twenty":-3.117868,"median":-0.702251,"eighty":-0.496147,"marketCap":15396196},{"date":"2025-10-10","current":-0.286819,"twenty":-3.087926,"median":-0.700124,"eighty":-0.489482,"marketCap":17474998},{"date":"2025-10-17","current":-0.382132,"twenty":-3.07358,"median":-0.697587,"eighty":-0.489482,"marketCap":23282157},{"date":"2025-10-24","current":-0.390477,"twenty":-3.042328,"median":-0.693548,"eighty":-0.48827,"marketCap":23790617},{"date":"2025-10-31","current":-0.538059,"twenty":-3.00719,"median":-0.691844,"eighty":-0.485279,"marketCap":32782347},{"date":"2025-11-07","current":-0.453007,"twenty":-2.916468,"median":-0.687751,"eighty":-0.483534,"marketCap":26279400},{"date":"2025-11-14","current":-0.450864,"twenty":-2.87069,"median":-0.681733,"eighty":-0.477564,"marketCap":26155062},{"date":"2025-11-21","current":-0.537929,"twenty":-2.83157,"median":-0.679358,"eighty":-0.474718,"marketCap":31205782},{"date":"2025-11-28","current":-0.822955,"twenty":-2.635253,"median":-0.677199,"eighty":-0.474718,"marketCap":47740442},{"date":"2025-12-05","current":-0.743521,"twenty":-2.53274,"median":-0.677199,"eighty":-0.474718,"marketCap":43132422},{"date":"2025-12-12","current":-0.665256,"twenty":-2.5124,"median":-0.674514,"eighty":-0.474718,"marketCap":38592167},{"date":"2025-12-19","current":-0.624955,"twenty":-2.467652,"median":-0.673806,"eighty":-0.474718,"marketCap":36254275},{"date":"2025-12-26","current":-0.747026,"twenty":-2.440803,"median":-0.672773,"eighty":-0.474718,"marketCap":43335717},{"date":"2026-01-02","current":-0.857506,"twenty":-2.419649,"median":-0.672773,"eighty":-0.474718,"marketCap":49744761},{"date":"2026-01-09","current":-0.821248,"twenty":-2.371647,"median":-0.672773,"eighty":-0.474718,"marketCap":47641389},{"date":"2026-01-14","current":-0.807349,"twenty":-2.369206,"median":-0.672773,"eighty":-0.474718,"marketCap":46835096}],"updateTime":1768547968115},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NXTC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586607742","title":"NextCure files to sell 2.52M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2586607742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586607742?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:05","pubTimestamp":1764191141,"startTime":"0","endTime":"0","summary":"16:02 EST NextCure (NXTC) files to sell 2.52M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nextcure-files-to-sell-2-52m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nextcure-files-to-sell-2-52m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NXTC"],"gpt_icon":0},{"id":"2586260600","title":"BRIEF-NextCure Files For Offering Of Up To 2.52 Million Shares Of Common Stock By Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260600","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586260600?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:03","pubTimestamp":1764190998,"startTime":"0","endTime":"0","summary":"BRIEF-NextCure Files For Offering Of Up To 2.52 Million Shares Of Common Stock By Selling Stockholders - SEC FilingNov 26  - NextCure Inc NXTC.O:NEXTCURE INC FILES FOR OFFERING OF UP TO 2.52 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILINGSource text: [ID:n0001104659-25-116418]Further company coverage: NXTC.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X210R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2584268116","title":"NextCure announces closing of $21.5M PIPE financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584268116","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584268116?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:16","pubTimestamp":1763385363,"startTime":"0","endTime":"0","summary":"NextCure (NXTC)announced the closing of its previously announced private placement in public equity. The PIPE was led by Ikarian Capital, Squadron ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nextcure-announces-closing-of-21-5m-pipe-financing-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nextcure-announces-closing-of-21-5m-pipe-financing-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXTC","PIPE","BK4139"],"gpt_icon":0},{"id":"2584625950","title":"NextCure Raises $21.5 Million in PIPE Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584625950","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584625950?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:05","pubTimestamp":1763384706,"startTime":"0","endTime":"0","summary":"NextCure Inc. has announced the closing of a $21.5 million private placement, in which the company sold 708,428 shares of common stock at $8.52 per share and pre-funded warrants to purchase up to 1,815,049 shares of common stock at $8.519 per warrant. The securities were sold in a private placement exempt from SEC registration requirements, with H.C. Wainwright & Co. acting as the exclusive placement agent. The financing was led by Ikarian Capital, Squadron Capital Management, Affinity Healthcare Fund, and Exome Asset Management, and will extend NextCure's cash runway into the first half of 2027, supporting ongoing development of its antibody drug conjugate programs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. publishe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL8VCMvk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","BK4588","LU0314104364.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4139","IE00B64PRP62.GBP","LU2210150020.SGD","NDAQ","NXTC","LU2210149790.SGD","LU2095319765.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2584625569","title":"Press Release: NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts","url":"https://stock-news.laohu8.com/highlight/detail?id=2584625569","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584625569?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:01","pubTimestamp":1763384460,"startTime":"0","endTime":"0","summary":"-- Extends cash runway into first half of 2027, beyond planned first half of. 2026 proof of concept  data readouts of SIM0505  and. -- Led by Ikarian Capital, Squadron Capital Management, Affinity Healthcare. Fund, and Exome Asset Management in a private placement of common stock. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","PIPE","BK4139","NXTC","BK4080","BK4231"],"gpt_icon":0},{"id":"2582379287","title":"NextCure Raises $21.5 Million in Private Placement of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2582379287","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582379287?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952426,"startTime":"0","endTime":"0","summary":"NextCure Inc., a clinical-stage biopharmaceutical company, announced it has entered into agreements with institutional and accredited investors for a private placement of approximately 2.5 million shares of common stock or pre-funded warrants at $8.52 per share, raising around $21.5 million. The offering, conducted under Section 4 of the Securities Act and Regulation D, is not registered under federal or state securities laws. H.C. Wainwright & Co. acted as the exclusive placement agent. NextCure plans to use the net proceeds for general working capital and to extend its cash runway into the first half of 2027, supporting continued development of its two antibody drug conjugate programs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL3NbBtH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","BK4139","IE00BKPKM429.USD","LU0314104364.USD","BK4112","LU2210149790.SGD","BK4588","NXTC","LU2210150020.SGD","NDAQ","IE00B64PRP62.GBP","BK4585","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2582379744","title":"NextCure Inc - Proceeds to Extend Cash Runway Into First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2582379744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582379744?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952411,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUA5PBBHH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NXTC"],"gpt_icon":0},{"id":"2582797583","title":"Press Release: NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2582797583","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582797583?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952400,"startTime":"0","endTime":"0","summary":"BELTSVILLE, Md., Nov. 12, 2025  -- NextCure, Inc. , a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, today announced that it has entered into definitive agreements with the participation of certain institutional and accredited investors, including Ikarian Capital, Squadron Capital Management, Affinity Healthcare Fund, LP., Exome Asset Management as well as other healthcare focused funds, for the purchase and sale of an aggregate of 2,523,477 shares of common stock  at a purchase price of $8.52 per share of common stock  in a private placement priced at-the-market under Nasdaq rules. The private placement is expected to close on or about November 13, 2025, subject to the satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.NextCure is a clinical-stage biopharmaceutical company that is focused on advancing innovative medicines that treat cancer patients that do not","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QLD","NXTC","QQQ",".IXIC","QID","BK4139","MNQmain","USAW.SI","PSQ","TQQQ","BK4080","TSYW.SI","SQQQ","BK4231","ADC","NQmain","USJW.SI","NVIW.SI"],"gpt_icon":0},{"id":"2581297888","title":"NextCure Raised to Buy From Neutral by Ladenburg Thalmann","url":"https://stock-news.laohu8.com/highlight/detail?id=2581297888","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581297888?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:00","pubTimestamp":1762520400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NXTC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 07, 2025 08:00 ET (13:00 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2581008342","title":"Biopharmaceutical firm NextCure Q3 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2581008342","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581008342?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:33","pubTimestamp":1762382023,"startTime":"0","endTime":"0","summary":"Biopharmaceutical firm NextCure Q3 net loss narrowsOverviewNextCure Q3 net loss decreases compared to same period last yearCompany advances ADC programs with U.S. enrollment and FDA clearance for prot","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL1N3WH1GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2581707332","title":"NextCure Inc. Highlights Progress in Targeted Cancer Therapies and ADC Trials in New Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2581707332","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581707332?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:32","pubTimestamp":1762378333,"startTime":"0","endTime":"0","summary":"NextCure Inc. provided an update on its ongoing research and development programs in a recent corporate presentation. The company highlighted progress in its Phase 1 clinical trials, focusing on two differentiated antibody-drug conjugates  targeting CDH6 and B7-H4, with preclinical and early clinical data discussed. NextCure is collaborating with Simcere Zaiming on the development of these programs. The next milestone for the company is the release of proof-of-concept  data, anticipated in the first half of 2026. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief on November 05, 2025, and is solely resp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL930M3J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"gpt_icon":0},{"id":"2580129264","title":"NextCure Inc  expected to post a loss of $3.98 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580129264","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580129264?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:47","pubTimestamp":1762170426,"startTime":"0","endTime":"0","summary":"NextCure Inc  expected to post a loss of $3.98 a share - Earnings Preview NextCure Inc NXTC.OQ NXTC.O is expected to  show no change in quarterly revenue when it reports  results on November 5 (estima","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF0TH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2575264728","title":"NextCure Inc. Releases Corporate Presentation Highlighting Progress of Targeted Cancer Therapies and Ongoing Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2575264728","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575264728?lang=en_us&edition=fundamental","pubTime":"2025-10-16 23:12","pubTimestamp":1760627533,"startTime":"0","endTime":"0","summary":"NextCure Inc. provided an update on its ongoing clinical programs in its latest corporate presentation. The company reported progress on two differentiated antibody-drug conjugate  programs that are currently in Phase 1 trials. These programs, LNCB74 targeting CDH6 with a TOPO payload and another targeting B7-H4 with an MMAE payload, are being developed in collaboration with Simcere Zaiming. NextCure anticipates proof-of-concept  data for both ADCs in the first half of 2026. The presentation also provided an overview of research and development milestones and outlined the company's ongoing efforts in the development of targeted therapies for cancer. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investme","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL81CSG1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2575074517","title":"BRIEF-NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The US","url":"https://stock-news.laohu8.com/highlight/detail?id=2575074517","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575074517?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:06","pubTimestamp":1760616405,"startTime":"0","endTime":"0","summary":"BRIEF-NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The USOct 16 (Reuters) - NextCure Inc NXTC.O:NEXTCURE AND SIMCERE ZAIMING ANNOUNCE EXPANSION OF ONGOING P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA6ZQ3RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK1191","BK1583","BK4139","02096"],"gpt_icon":0},{"id":"2575174518","title":"NextCure and Simcere Zaiming Expand Phase 1 Trial of SIM0505 (CDH6 ADC) into U.S.; First American Patient Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2575174518","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575174518?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:05","pubTimestamp":1760616316,"startTime":"0","endTime":"0","summary":"NextCure Inc. and Simcere Zaiming have announced the expansion of the ongoing Phase 1 clinical trial of SIM0505, a novel antibody drug conjugate targeting cadherin-6 , into the United States. The first U.S. patient has been dosed at a mid-tier dose level where multiple responses have previously been observed. The multi-regional trial, which began in China, is evaluating safety, tolerability, pharmacokinetics, and efficacy in patients with advanced solid tumors. NextCure expects to present proof-of-concept clinical data in the first half of 2026. No clinical results have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via GlobeNewswire  on O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL51tgV4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4585","NXTC","BK4139","BK4112","NDAQ","LU0314104364.USD","LU2210149790.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","IE00BKPKM429.USD","LU2095319765.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2575459727","title":"NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of Sim0505 (Cdh6 ADC) Into the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2575459727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575459727?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:05","pubTimestamp":1760616300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA6ZQ3RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02096","BK4139","NXTC","BK1191","BK1583"],"gpt_icon":0},{"id":"2575074590","title":"NextCure Inc - Trial to Accelerate Proof-of-Concept Data in 1H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2575074590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575074590?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:05","pubTimestamp":1760616300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA6ZQ3RM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","02096","BK4139","NXTC","BK1191"],"gpt_icon":0},{"id":"2564844522","title":"NextCure Inc. Unveils Latest Developments in Cancer Therapy Targeting and Clinical Trials Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2564844522","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564844522?lang=en_us&edition=fundamental","pubTime":"2025-09-02 03:10","pubTimestamp":1756753826,"startTime":"0","endTime":"0","summary":"NextCure Inc. has released a corporate presentation outlining their current and future initiatives in the field of targeted cancer therapy. The document details ongoing Phase 1 clinical trials involving two differentiated antibody-drug conjugates . Additionally, the presentation highlights the company's co-development efforts with Simcere, targeting proteins B7-H4 and CDH6, with payloads MMAE and TOPOi, respectively. Preclinical and Phase 1 milestones are anticipated, with proof-of-concept data expected in the first half of 2026. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief on September 01, 2025, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nNDLbrwxT3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"gpt_icon":0},{"id":"2562277812","title":"NextCure Inc. Announces Resignation of Chief Scientific Officer Solomon Langermann, Effective September 1, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2562277812","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562277812?lang=en_us&edition=fundamental","pubTime":"2025-08-26 04:11","pubTimestamp":1756152709,"startTime":"0","endTime":"0","summary":"NextCure Inc. announced that Solomon Langermann, Ph.D., has resigned from his position as Chief Scientific Officer, effective September 1, 2025. The company confirmed that his resignation was not due to any disagreements related to company operations or policies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDLbLTTLV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2560104144","title":"NextCure Inc. Files Initial Statement of Beneficial Ownership for Simcere Zaiming, Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2560104144","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560104144?lang=en_us&edition=fundamental","pubTime":"2025-08-20 09:33","pubTimestamp":1755653581,"startTime":"0","endTime":"0","summary":"NextCure Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing mentions Simcere Zaiming, Inc. as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL3RwYL0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}]}}